Literature DB >> 8894195

Psychological predictors of insight and compliance in psychotic patients.

R Kemp1, A David.   

Abstract

BACKGROUND: A possible neuropsychological basis for poor insight in psychosis has been proposed. Consistent supporting evidence for this is lacking.
METHOD: Seventy-four consecutive acutely psychotic in-patients who were recruited for a randomised controlled trial of compliance therapy were given a battery of neuropsychological tests, along with a comprehensive clinical assessment, before and after the intervention.
RESULTS: Performance on neuropsychological tests improved during the patients' admission and treatment in hospital, as did symptoms and levels of insight. Cognitive function showed no relationship to insight and compliance initially, and very little after the intervention. Factors related to insight and compliance prior to discharge included: diagnosis, attitudes to medication, side-effects, being a detained patient, and whether or not compliance therapy was given.
CONCLUSIONS: Clinical variables and attitudes to treatment appear to be more relevant to compliance and the development of insight in acute psychosis than neuropsychological impairment.

Entities:  

Mesh:

Year:  1996        PMID: 8894195     DOI: 10.1192/bjp.169.4.444

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  29 in total

1.  Factors influencing compulsory admission in first-admitted subjects with psychosis.

Authors:  Audrey Cougnard; Ester Kalmi; Alain Desage; David Misdrahi; François Abalan; Hélène Brun-Rousseau; Louis Rachid Salmi; Hélène Verdoux
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2004-10       Impact factor: 4.328

2.  Insight in psychosis: relationship with neurocognition, social cognition and clinical symptoms depends on phase of illness.

Authors:  Piotr J Quee; Lisette van der Meer; Richard Bruggeman; Lieuwe de Haan; Lydia Krabbendam; Wiepke Cahn; Niels C L Mulder; Durk Wiersma; André Aleman
Journal:  Schizophr Bull       Date:  2010-11-22       Impact factor: 9.306

Review 3.  Lack of insight in schizophrenia: impact on treatment adherence.

Authors:  Peter F Buckley; Donna A Wirshing; Prameet Bhushan; Joseph M Pierre; Seth A Resnick; William C Wirshing
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

4.  Costs of new atypical antipsychotic agents for schizophrenia: does unrestricted access reduce hospital utilization?

Authors:  Daria O'Reilly; David Craig; Leslie Phillips; Ron Goeree; Jean-Eric Tarride; Patrick Parfrey
Journal:  Healthc Policy       Date:  2007-08

5.  Structural models describing placebo treatment effects in schizophrenia and other neuropsychiatric disorders.

Authors:  Venkatesh Pilla Reddy; Magdalena Kozielska; Martin Johnson; An Vermeulen; Rik de Greef; Jing Liu; Geny M M Groothuis; Meindert Danhof; Johannes H Proost
Journal:  Clin Pharmacokinet       Date:  2011-07       Impact factor: 6.447

Review 6.  The effects of aging on insight into illness in schizophrenia: a review.

Authors:  Philip Gerretsen; Eric Plitman; Tarek K Rajji; Ariel Graff-Guerrero
Journal:  Int J Geriatr Psychiatry       Date:  2014-07-23       Impact factor: 3.485

7.  Frontotemporoparietal asymmetry and lack of illness awareness in schizophrenia.

Authors:  Philip Gerretsen; M Mallar Chakravarty; David Mamo; Mahesh Menon; Bruce G Pollock; Tarek K Rajji; Ariel Graff-Guerrero
Journal:  Hum Brain Mapp       Date:  2012-01-03       Impact factor: 5.038

8.  The clinical applicability of the Self-Appraisal of Illness Questionnaire (SAIQ) to chronic schizophrenic patients in Taiwan.

Authors:  Yu-Chen Kao; Yia-Ping Liu
Journal:  Psychiatr Q       Date:  2010-09

Review 9.  Disorders of awareness in neuropsychiatric syndromes: an update.

Authors:  Laura A Flashman
Journal:  Curr Psychiatry Rep       Date:  2002-10       Impact factor: 5.285

10.  Attitudes toward medication and the clinical variables in schizophrenia: Structural equation models.

Authors:  Alessandro Rossi; Roberta Pacifico; Paolo Stratta
Journal:  Patient Prefer Adherence       Date:  2009-11-03       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.